The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
International collaboration in personalized medicine for the treatment of advanced and drug-refractory cancers: Clinical application of human tumor primary culture analyses.
Fabricio Colacino Silva
No relevant relationships to disclose
Fernando C. Maluf
No relevant relationships to disclose
Antonio C. Buzaid
No relevant relationships to disclose
Robert Alan Nagourney
Employment or Leadership Position - Rational Therapeutics
Stock Ownership - Rational Therapeutics
Nise Hitomi Yamaguchi
No relevant relationships to disclose
Paulo D'Amora
Employment or Leadership Position - Centro de Genomas
Steven Evans
Employment or Leadership Position - Rational Therapeutics
Paula J Bernard
Employment or Leadership Position - Rational Therapeutics
Federico Francisco
Employment or Leadership Position - Rational Therapeutics